Celgene's VIDAZA® (Azacitidine For Injection) Approved By The European Commission As New Treatment For Elderly Patients With Acute Myeloid Leukaemia

Celgene's VIDAZA® (Azacitidine For Injection) Approved By The European Commission As New Treatment For Elderly Patients With Acute Myeloid Leukaemia